Vitamin E (d-alpha-tocopheryl-co-poly(ethylene glycol) 1000 succinate) micelles-superparamagnetic iron oxide nanoparticles for enhanced thermotherapy and MRI

Biomaterials

Volumn 32, Issue 24, 2011, Pages 5663-5672

  Chandrasekharan, Prashant ^a   Maity, Dipak ^a   Yong, Cai Xian ^b   Chuang, Kai Hsiang ^b   Ding, Jun ^a   Feng, Si Shen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b AGENCY FOR SCIENCE   (Singapore)

Author keywords

Cancer nanotechnology; Colloidal stability; Magnetic micelles; Molecular imaging; Nanothermotherapy; Xenograft tumor model

Indexed keywords

CANCER NANOTECHNOLOGY; COLLOIDAL STABILITY; MAGNETIC MICELLES; MOLECULAR IMAGING; NANOTHERMOTHERAPY; XENOGRAFT TUMOR MODEL;

BIOLOGICAL MATERIALS; BIOSYNTHESIS; CRITICAL MICELLE CONCENTRATION; DISEASES; ETHYLENE; ETHYLENE GLYCOL; IRON; IRON OXIDES; MAGNETIC PROPERTIES; MAGNETIC RESONANCE IMAGING; OLEIC ACID; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES; RESONANCE; SALINE WATER; SUPERPARAMAGNETISM; TRANSMISSION ELECTRON MICROSCOPY; TUMORS;

MICELLES;

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; TOCOFERSOLAN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG FORMULATION; HUMAN; HUMAN CELL; HYPERTHERMIC THERAPY; IN VITRO STUDY; MICELLE; NANOTECHNOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SOLUTION AND SOLUBILITY; SUSPENSION; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; MICELLES; NANOPARTICLES; POLYETHYLENE GLYCOLS; VITAMIN E; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 79957958314     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.037     Document Type: Article

References (39)

1. Palmacci S, and Josephson L. Synthesis of polysaccharide covered superparamagnetic oxide colloids. U.S patent 5,262,17; November 16 1993.
2. Alexiou C., Arnold W., Hulin P., Klein R.J., Renz H., Parak F.G., et al. Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting. J Magn Magn Mater 2001, 225:187-193.
3. Maity D., Chandrasekharan P., Feng S.-S., Xue J.-M., Ding J. Polyol-based synthesis of hydrophilic magnetite nanoparticles. J Appl Phys 2010, 107. 09B310.
4. Lee S.J., Jeong J.R., Shin S.C., Kim J.C., Chang Y.H., Lee K.H. Magnetic enhancement of iron oxide nanoparticles encapsulated with poly(d, l-latide-co-glycolide). Colloid Surf A 2005, 255:19-25.
5. Prashant C., Dipak M., Yang C.T., Chuang K.H., Jun D., Feng S.S. Superparamagnetic iron oxide-loaded poly (lactic acid)-d-α-tocopherol polyethylene glycol 1000 succinate copolymer nanoparticles as MRI contrast agent. Biomaterials 2010, 31:5588-5597.
6. Allen C., Maysinger D., Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B 1999, 16:3-27.
7. Kabanov A.V., Alakhov V.Y. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. Crit Rev Ther Drug 2002, 19:1-72.
8. Torchilin V.P. Structure and design of polymeric surfactant-based drug delivery systems. J Control Release 2001, 73:137-172.
9. Jones M.C., Leroux J.C. Polymeric micelles-a new generation of colloidal drug carriers. Eur J Pharm Biopharm 1999, 48:101-111.
10. Kwon G.S., Kataoka K. Block copolymer micelles as long-circulating drug vehicles. Adv Drug Deliv Rev 1995, 16:295-309.
11. Mi Y., Liu Y., Feng S.S. Formulation of docetaxel by folic acid-conjugated d-a-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS2k) micelles for targeted and synergistic chemotherapy. Biomaterials 2011, 32:4058-4066.
12. Miles W.C., Goff J.D., Huffstetler P.P., Reinholz C.M., Pothayee N., Caba B.L., et al. Synthesis and colloidal properties of polyether-magnetite complexes in water and phosphate-buffered saline. Langmuir 2009, 25:803-831.
13. Letchford K., Burt H. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymerosomes. Eur J Pharm Biopharm 2007, 65:259-269.
14. Kim B.S., Qiu J.M., Wang J.P., Taton T.A. Magnetomicelles: composite nanostructures from magnetic nanoparticles and cross-linked amphiphilic block copolymers. Nano Lett 2005, 5:1987-1991.
15. Khattak S.F., Bhatia S.R., Robers S.C. Pluronic F127 as a cell encapsulation material: utilization of membrane-stabilizing agents. Tissue Eng 2005, 11:974-983.
16. Sonoda A., Nitta N., Ohta S., Nitta-Seko A., Morikawa S., Tabata Y., et al. Controlled release and antitumor effect of pluronic F127 mixed with cisplatin in a rabbit model. Cardiovasc Intervent Radiol 2010, 33:135.
17. Jain T.K., Foy S.P., Erokwu B., Dimitrijevic S., Flask C.A., Labhasetwar V. Magnetic resonance imaging of multifunctional pluronic stabilized iron-oxide nanoparticles in tumor-bearing mice. Biomaterials 2009, 30:6748-6756.
18. Jain T.K., Richey J., Strand M., Leslie-Pelecky D.L., Flask C.A., Labhasetwar V. Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging. Biomaterials 2008, 29:4012-4021.
19. Lai J.R., Chang Y.W., Yen H.C., Yuan N.Y., Liao M.Y., Hsu C.Y., et al. Multifunctional doxorubicin/superparamagnetic iron oxide-encapsulated pluronic F127 micelles used for chemotherapy/magnetic resonance imaging. J Appl Phys 2010, 107. 09B318.
20. Dintaman J.M., Silverman J.A. Inhibition of p-glycoprotein by d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999, 16:1550-1556.
21. Johnson B.M., Charman W.N., Porter C.J.H. An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate on p-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine. AAPS PharmSci 2002, 4(4):E40.
22. Varma M.V.S., Panchagnula R. Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. Eur J Pharm Sci 2005, 25:445-453.
23. Collnot E.M., Baldes C., Schaefer U.F., Edgar K.J., Wempe M.F., Lehr C.M. Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. Mol Pharmaceutics 2010, 7:642-651.
24. Zhang Z., Feng S.S. Nanoparticles of poly(lactide)/vitamin E TPGS copolymer for cancer chemotherapy: synthesis, formulation, characterization and in vitro drug release. Biomaterials 2006, 27:262-270.
25. Zhang Z., Lee S.H., Gan C.W., Feng S.S. In vitro and in vivo investigation on PLA-TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm Res 2008, 25:1925-1935.
26. Anbharasi V., Cao N., Feng S.S. Doxorubicin conjugated to d-α-tocopheryl polyethylene glycol succinate and folic acid as a prodrug for targeted chemotherapy. J Biomed Mater Res A 2010, 94:730-743.
27. Cao N., Feng S.S. Doxorubicin conjugated to d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS): conjugation chemistry, characterization, in vitro and in vivo evaluation. Biomaterials 2008, 29:3856-3865.
28. Dipak M., Choo S.G., Yi J., Jun D., Xue J.M. Synthesis of magnetite nanoparticles via a solvent-free thermal decomposition route. J Magn Magn Mater 2009, 321:1256.
29. Maity D., Chandrasekharan P., Yang C.-T., Chuang K.-H., Shuter B., Xue J.-M., et al. Facile synthesis of water-soluble magnetite nanoparticles for clinical MRI and magnetic hyperthermia applications. Nanomedicine 2010, 5:1571-1584.
30. Pandit N., Trygstad T., Croy S., Bohoquez M., Koch C. Effect of salts on the micellization, clouding and solubilization behaviour of pluronics F127 solutions. J Colloid Interface Sci 2000, 222:213-220.
31. Rosen M.J. Surfactants and interfacial phenomena 2004, Wiley-Interscience. 3rd ed. N.J. Hoboken (Ed.).
32. Gelbert W.M., Ben-Shaul A., Roux D. Micelles, membranes, microemulsions, and monolayers 1994, Springer-Verlag, New York.
33. Maity D., Agarwal D.C. Synthesis of iron oxide nanoparticles under oxidizing environment and their stabilization in aqueous and non-aqueous media. J Magn Magn Mater 2007, 308:46-55.
34. Jin J.M. - Electromagnetic analysis and design in magnetic resonance imaging 1998, CRC Press, Boca Raton.
35. Wang X., Gu H., Yang Z. The heating effect of magnetic fluids in an alternating magnetic field. J Magn Magn Mater 2005, 293:334-340.
36. Schinkel A.H., Smit J.J., Van Tellingen O., Beijnen J.H., Wagenaar E., Van Deemter L., et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
37. Van Asperen J., Van Tellingen O., Sparreboom A., Schinkel A.H., Borst P., Nooijen W.J., et al. Enhanced oval bioavailability of paclitaxel in mice treated with the P-glycoprotein blocker SDZ PSC 833. Br J Cancer 1997, 76:1181-1183.
38. Moghimi S.M., Porter C.J., Muir I.S., Illum L., Davis S.S. Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun 1991, 177:861-866.
39. Hao Y.L., Deng Y.J., Chen Y., Wang K.Z., Hao A.J., Zhang Y. In-vitro cytotoxicity, in-vivo biodistribution and antitumor effect of PEGylated liposomal topotecan. J Pharm Pharmacol 2005, 57:1279-1287.